0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Attention Deficit and Hyperactivity Disorder Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-25W5936
Home | Market Reports | Health| Health Conditions| Neurological Conditions
Global Attention Deficit Hyperactivity Disorder Market Insights and Forecast to 2028
BUY CHAPTERS

Global Attention Deficit and Hyperactivity Disorder Market Research Report 2025

Code: QYRE-Auto-25W5936
Report
February 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Attention Deficit and Hyperactivity Disorder Market Size

The global market for Attention Deficit and Hyperactivity Disorder was valued at US$ 21790 million in the year 2024 and is projected to reach a revised size of US$ 34770 million by 2031, growing at a CAGR of 7.0% during the forecast period.

Attention Deficit and Hyperactivity Disorder Market

Attention Deficit and Hyperactivity Disorder Market

Attention deficit hyperactivity disorder (ADHD) is a condition that affects people"s behaviour. People with ADHD can seem restless, may have trouble concentrating and may act on impulse.
The Attention Deficit and Hyperactivity Disorder (ADHD) market is driven by the rising awareness of the disorder and its diagnosis, coupled with the increasing prevalence of ADHD among children and adults. ADHD is a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity. The growing recognition of the impact of ADHD on daily life, educational performance, and workplace productivity contributes to market growth as individuals and healthcare providers seek effective treatment options. Moreover, advancements in diagnostic methods, therapy approaches, and medication options align with improved management of ADHD symptoms. However, the market also faces challenges, including accurate diagnosis and tailoring treatment plans to individual patient needs. Additionally, addressing concerns about overdiagnosis and appropriate medication usage can pose obstacles for healthcare professionals. To succeed, stakeholders must focus on providing comprehensive assessment and tailored interventions, fostering public awareness, and addressing the challenges to meet the increasing demand for accurate diagnosis and effective management of ADHD.
This report aims to provide a comprehensive presentation of the global market for Attention Deficit and Hyperactivity Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Attention Deficit and Hyperactivity Disorder.
The Attention Deficit and Hyperactivity Disorder market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Attention Deficit and Hyperactivity Disorder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Attention Deficit and Hyperactivity Disorder companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Attention Deficit and Hyperactivity Disorder Market Report

Report Metric Details
Report Name Attention Deficit and Hyperactivity Disorder Market
Accounted market size in year US$ 21790 million
Forecasted market size in 2031 US$ 34770 million
CAGR 7.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Stimulant
  • Non-stimulant
Segment by Application
  • Hospital
  • Retail Pharmacy
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals, Noven Pharmaceuticals, Purdue Parma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Attention Deficit and Hyperactivity Disorder company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Attention Deficit and Hyperactivity Disorder Market growing?

Ans: The Attention Deficit and Hyperactivity Disorder Market witnessing a CAGR of 7.0% during the forecast period 2025-2031.

What is the Attention Deficit and Hyperactivity Disorder Market size in 2031?

Ans: The Attention Deficit and Hyperactivity Disorder Market size in 2031 will be US$ 34770 million.

Who are the main players in the Attention Deficit and Hyperactivity Disorder Market report?

Ans: The main players in the Attention Deficit and Hyperactivity Disorder Market are Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals, Noven Pharmaceuticals, Purdue Parma

What are the Application segmentation covered in the Attention Deficit and Hyperactivity Disorder Market report?

Ans: The Applications covered in the Attention Deficit and Hyperactivity Disorder Market report are Hospital, Retail Pharmacy, Others

What are the Type segmentation covered in the Attention Deficit and Hyperactivity Disorder Market report?

Ans: The Types covered in the Attention Deficit and Hyperactivity Disorder Market report are Stimulant, Non-stimulant

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Stimulant
1.2.3 Non-stimulant
1.3 Market by Application
1.3.1 Global Attention Deficit and Hyperactivity Disorder Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Attention Deficit and Hyperactivity Disorder Market Perspective (2020-2031)
2.2 Global Attention Deficit and Hyperactivity Disorder Growth Trends by Region
2.2.1 Global Attention Deficit and Hyperactivity Disorder Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Attention Deficit and Hyperactivity Disorder Historic Market Size by Region (2020-2025)
2.2.3 Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Region (2026-2031)
2.3 Attention Deficit and Hyperactivity Disorder Market Dynamics
2.3.1 Attention Deficit and Hyperactivity Disorder Industry Trends
2.3.2 Attention Deficit and Hyperactivity Disorder Market Drivers
2.3.3 Attention Deficit and Hyperactivity Disorder Market Challenges
2.3.4 Attention Deficit and Hyperactivity Disorder Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Attention Deficit and Hyperactivity Disorder Players by Revenue
3.1.1 Global Top Attention Deficit and Hyperactivity Disorder Players by Revenue (2020-2025)
3.1.2 Global Attention Deficit and Hyperactivity Disorder Revenue Market Share by Players (2020-2025)
3.2 Global Attention Deficit and Hyperactivity Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Attention Deficit and Hyperactivity Disorder Revenue
3.4 Global Attention Deficit and Hyperactivity Disorder Market Concentration Ratio
3.4.1 Global Attention Deficit and Hyperactivity Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Attention Deficit and Hyperactivity Disorder Revenue in 2024
3.5 Global Key Players of Attention Deficit and Hyperactivity Disorder Head office and Area Served
3.6 Global Key Players of Attention Deficit and Hyperactivity Disorder, Product and Application
3.7 Global Key Players of Attention Deficit and Hyperactivity Disorder, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Attention Deficit and Hyperactivity Disorder Breakdown Data by Type
4.1 Global Attention Deficit and Hyperactivity Disorder Historic Market Size by Type (2020-2025)
4.2 Global Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Type (2026-2031)
5 Attention Deficit and Hyperactivity Disorder Breakdown Data by Application
5.1 Global Attention Deficit and Hyperactivity Disorder Historic Market Size by Application (2020-2025)
5.2 Global Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Attention Deficit and Hyperactivity Disorder Market Size (2020-2031)
6.2 North America Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025)
6.4 North America Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Attention Deficit and Hyperactivity Disorder Market Size (2020-2031)
7.2 Europe Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025)
7.4 Europe Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size (2020-2031)
8.2 Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size by Region (2020-2025)
8.4 Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Attention Deficit and Hyperactivity Disorder Market Size (2020-2031)
9.2 Latin America Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025)
9.4 Latin America Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size (2020-2031)
10.2 Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025)
10.4 Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Attention Deficit and Hyperactivity Disorder Introduction
11.1.4 Takeda Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025)
11.1.5 Takeda Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Attention Deficit and Hyperactivity Disorder Introduction
11.2.4 Johnson & Johnson Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025)
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Attention Deficit and Hyperactivity Disorder Introduction
11.3.4 Novartis Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Attention Deficit and Hyperactivity Disorder Introduction
11.4.4 Eli Lilly Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025)
11.4.5 Eli Lilly Recent Development
11.5 Tris Pharma
11.5.1 Tris Pharma Company Details
11.5.2 Tris Pharma Business Overview
11.5.3 Tris Pharma Attention Deficit and Hyperactivity Disorder Introduction
11.5.4 Tris Pharma Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025)
11.5.5 Tris Pharma Recent Development
11.6 Neos Therapeutics
11.6.1 Neos Therapeutics Company Details
11.6.2 Neos Therapeutics Business Overview
11.6.3 Neos Therapeutics Attention Deficit and Hyperactivity Disorder Introduction
11.6.4 Neos Therapeutics Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025)
11.6.5 Neos Therapeutics Recent Development
11.7 Mallinckrodt
11.7.1 Mallinckrodt Company Details
11.7.2 Mallinckrodt Business Overview
11.7.3 Mallinckrodt Attention Deficit and Hyperactivity Disorder Introduction
11.7.4 Mallinckrodt Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025)
11.7.5 Mallinckrodt Recent Development
11.8 Amneal Pharmaceuticals
11.8.1 Amneal Pharmaceuticals Company Details
11.8.2 Amneal Pharmaceuticals Business Overview
11.8.3 Amneal Pharmaceuticals Attention Deficit and Hyperactivity Disorder Introduction
11.8.4 Amneal Pharmaceuticals Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025)
11.8.5 Amneal Pharmaceuticals Recent Development
11.9 Noven Pharmaceuticals
11.9.1 Noven Pharmaceuticals Company Details
11.9.2 Noven Pharmaceuticals Business Overview
11.9.3 Noven Pharmaceuticals Attention Deficit and Hyperactivity Disorder Introduction
11.9.4 Noven Pharmaceuticals Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025)
11.9.5 Noven Pharmaceuticals Recent Development
11.10 Purdue Parma
11.10.1 Purdue Parma Company Details
11.10.2 Purdue Parma Business Overview
11.10.3 Purdue Parma Attention Deficit and Hyperactivity Disorder Introduction
11.10.4 Purdue Parma Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025)
11.10.5 Purdue Parma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Stimulant
 Table 3. Key Players of Non-stimulant
 Table 4. Global Attention Deficit and Hyperactivity Disorder Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Attention Deficit and Hyperactivity Disorder Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Attention Deficit and Hyperactivity Disorder Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Attention Deficit and Hyperactivity Disorder Market Share by Region (2020-2025)
 Table 8. Global Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Attention Deficit and Hyperactivity Disorder Market Share by Region (2026-2031)
 Table 10. Attention Deficit and Hyperactivity Disorder Market Trends
 Table 11. Attention Deficit and Hyperactivity Disorder Market Drivers
 Table 12. Attention Deficit and Hyperactivity Disorder Market Challenges
 Table 13. Attention Deficit and Hyperactivity Disorder Market Restraints
 Table 14. Global Attention Deficit and Hyperactivity Disorder Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Attention Deficit and Hyperactivity Disorder Market Share by Players (2020-2025)
 Table 16. Global Top Attention Deficit and Hyperactivity Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit and Hyperactivity Disorder as of 2024)
 Table 17. Ranking of Global Top Attention Deficit and Hyperactivity Disorder Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Attention Deficit and Hyperactivity Disorder Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Attention Deficit and Hyperactivity Disorder, Headquarters and Area Served
 Table 20. Global Key Players of Attention Deficit and Hyperactivity Disorder, Product and Application
 Table 21. Global Key Players of Attention Deficit and Hyperactivity Disorder, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Attention Deficit and Hyperactivity Disorder Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Attention Deficit and Hyperactivity Disorder Revenue Market Share by Type (2020-2025)
 Table 25. Global Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Attention Deficit and Hyperactivity Disorder Revenue Market Share by Type (2026-2031)
 Table 27. Global Attention Deficit and Hyperactivity Disorder Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Attention Deficit and Hyperactivity Disorder Revenue Market Share by Application (2020-2025)
 Table 29. Global Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Attention Deficit and Hyperactivity Disorder Revenue Market Share by Application (2026-2031)
 Table 31. North America Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Takeda Company Details
 Table 47. Takeda Business Overview
 Table 48. Takeda Attention Deficit and Hyperactivity Disorder Product
 Table 49. Takeda Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)
 Table 50. Takeda Recent Development
 Table 51. Johnson & Johnson Company Details
 Table 52. Johnson & Johnson Business Overview
 Table 53. Johnson & Johnson Attention Deficit and Hyperactivity Disorder Product
 Table 54. Johnson & Johnson Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)
 Table 55. Johnson & Johnson Recent Development
 Table 56. Novartis Company Details
 Table 57. Novartis Business Overview
 Table 58. Novartis Attention Deficit and Hyperactivity Disorder Product
 Table 59. Novartis Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)
 Table 60. Novartis Recent Development
 Table 61. Eli Lilly Company Details
 Table 62. Eli Lilly Business Overview
 Table 63. Eli Lilly Attention Deficit and Hyperactivity Disorder Product
 Table 64. Eli Lilly Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)
 Table 65. Eli Lilly Recent Development
 Table 66. Tris Pharma Company Details
 Table 67. Tris Pharma Business Overview
 Table 68. Tris Pharma Attention Deficit and Hyperactivity Disorder Product
 Table 69. Tris Pharma Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)
 Table 70. Tris Pharma Recent Development
 Table 71. Neos Therapeutics Company Details
 Table 72. Neos Therapeutics Business Overview
 Table 73. Neos Therapeutics Attention Deficit and Hyperactivity Disorder Product
 Table 74. Neos Therapeutics Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)
 Table 75. Neos Therapeutics Recent Development
 Table 76. Mallinckrodt Company Details
 Table 77. Mallinckrodt Business Overview
 Table 78. Mallinckrodt Attention Deficit and Hyperactivity Disorder Product
 Table 79. Mallinckrodt Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)
 Table 80. Mallinckrodt Recent Development
 Table 81. Amneal Pharmaceuticals Company Details
 Table 82. Amneal Pharmaceuticals Business Overview
 Table 83. Amneal Pharmaceuticals Attention Deficit and Hyperactivity Disorder Product
 Table 84. Amneal Pharmaceuticals Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)
 Table 85. Amneal Pharmaceuticals Recent Development
 Table 86. Noven Pharmaceuticals Company Details
 Table 87. Noven Pharmaceuticals Business Overview
 Table 88. Noven Pharmaceuticals Attention Deficit and Hyperactivity Disorder Product
 Table 89. Noven Pharmaceuticals Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)
 Table 90. Noven Pharmaceuticals Recent Development
 Table 91. Purdue Parma Company Details
 Table 92. Purdue Parma Business Overview
 Table 93. Purdue Parma Attention Deficit and Hyperactivity Disorder Product
 Table 94. Purdue Parma Revenue in Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)
 Table 95. Purdue Parma Recent Development
 Table 96. Research Programs/Design for This Report
 Table 97. Key Data Information from Secondary Sources
 Table 98. Key Data Information from Primary Sources
 Table 99. Authors List of This Report


List of Figures
 Figure 1. Attention Deficit and Hyperactivity Disorder Picture
 Figure 2. Global Attention Deficit and Hyperactivity Disorder Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Attention Deficit and Hyperactivity Disorder Market Share by Type: 2024 VS 2031
 Figure 4. Stimulant Features
 Figure 5. Non-stimulant Features
 Figure 6. Global Attention Deficit and Hyperactivity Disorder Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Attention Deficit and Hyperactivity Disorder Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Case Studies
 Figure 9. Retail Pharmacy Case Studies
 Figure 10. Others Case Studies
 Figure 11. Attention Deficit and Hyperactivity Disorder Report Years Considered
 Figure 12. Global Attention Deficit and Hyperactivity Disorder Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Attention Deficit and Hyperactivity Disorder Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Attention Deficit and Hyperactivity Disorder Market Share by Region: 2024 VS 2031
 Figure 15. Global Attention Deficit and Hyperactivity Disorder Market Share by Players in 2024
 Figure 16. Global Top Attention Deficit and Hyperactivity Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit and Hyperactivity Disorder as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Attention Deficit and Hyperactivity Disorder Revenue in 2024
 Figure 18. North America Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Attention Deficit and Hyperactivity Disorder Market Share by Country (2020-2031)
 Figure 20. United States Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Attention Deficit and Hyperactivity Disorder Market Share by Country (2020-2031)
 Figure 24. Germany Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Attention Deficit and Hyperactivity Disorder Market Share by Region (2020-2031)
 Figure 32. China Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Attention Deficit and Hyperactivity Disorder Market Share by Country (2020-2031)
 Figure 40. Mexico Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Attention Deficit and Hyperactivity Disorder Market Share by Country (2020-2031)
 Figure 44. Turkey Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Takeda Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2020-2025)
 Figure 48. Johnson & Johnson Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2020-2025)
 Figure 49. Novartis Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2020-2025)
 Figure 50. Eli Lilly Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2020-2025)
 Figure 51. Tris Pharma Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2020-2025)
 Figure 52. Neos Therapeutics Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2020-2025)
 Figure 53. Mallinckrodt Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2020-2025)
 Figure 54. Amneal Pharmaceuticals Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2020-2025)
 Figure 55. Noven Pharmaceuticals Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2020-2025)
 Figure 56. Purdue Parma Revenue Growth Rate in Attention Deficit and Hyperactivity Disorder Business (2020-2025)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Neurology Equipment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32U11385
Wed Mar 05 00:00:00 UTC 2025

Add to Cart

Global Adult Attention Deficit and Hyperactivity Disorder Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32G9531
Fri Feb 28 00:00:00 UTC 2025

Add to Cart

Global Attention Deficit and Hyperactivity Disorder Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25W5936
Fri Feb 28 00:00:00 UTC 2025

Add to Cart

Global Children Attention Deficit and Hyperactivity Disorder Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13S9800
Fri Feb 28 00:00:00 UTC 2025

Add to Cart